Nordic Life Sciences VC Closes €100M Fund
Norway-based venture capital firm Hadean Ventures has now closed Hadean Capital I, its first fund that hoped to raise €100M thanks to investment from companies, including Argentum and Saminvest, which are financed by the Norwegian and Swedish governments, respectively.
Hadean will invest €6-€8 million ($7.1-$9.4 million) in about 10-12 European start-ups, with an emphasis on the Nordic region, and plans to make its first investment in 1Q18.
Ingrid Teigland Akay, Managing Partner of Hadean, commented on the gap in the market that the VC hopes to fill: “The Nordic region has outstanding scientists, a stable, business-friendly environment, and a vibrant start-up community, yet very few life science specialist venture funds are on the ground. We see an exceptionally strong deal flow of high potential opportunities here.”
